Navigation Links
Cranberry Capsule Proven to Cure Bladder Infection
Date:5/3/2012

AMSTERDAM, May 3, 2012 /PRNewswire/ --

Dutch Medical Brands receives first European Class IIa Medical Device Status

Instead of traditional treatment with antibiotics, bladder and urinary tract infections can be cured with cranberry capsules, without known side effects. Dutch company Medical Brands has obtained a Class IIa Medical Device Status for its patented Cranberry-Active capsule, making it the first and only cranberry-based product in Europe which has a proven medical claim.

Together with American company Decas Botanical Synergies (DBS), Medical Brands spent seven years developing the capsule and getting it patented and approved by the proper authorities.

While the claims of other cranberry-based food supplements will be rejected later this year by the European Food and Safety Authority (EFSA), Medical Brands produced studies which clinically showed that the capsule cures bladder infections. Compared to other cranberry products, MB and DBS developed a unique and proprietary formulation which is proven to treat and prevent bladder and urinary tract infections. It's the first capsule that can be freely sold as a medical device on the OTC market in all European countries.

"Bladder- and urinary tract infections (UTIs) are a serious health problem, affecting millions of people each year. Today, antibiotics are the traditional treatment for UTIs but there is a growing global push towards other solutions as resistance to antibiotics continues to rise. Our Cranberry-Active capsules marketing authorization is the culmination of years of planning, development and clinical investigation," says Maikel Hendriks, president of Medical Brands.

His company is specialised in developing medical devices without pharmacologic effects. It provides consumers with solutions for everyday diseases without the side effects most drugs have.

In the Netherlands the capsule is sold as the Bladder Infection Tablet by 'i say', in other countries Medical Brands is still searching for partners to sell the capsule. To inform potential market partners and consumers Medical Brands and DBS will present their Cranberry-Active capsules at the Vitafoods Europe 2012 conference in Geneva, Switzerland, at the Seminar Theater on Tuesday, May 22nd at 2:00 PM.


'/>"/>
SOURCE Medical Brands
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Research Shows Decas Sweetened Dried Cranberries Pack Twice the Proanthocyanidin Punch as Cranberry Juice Cocktail
2. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
3. GSK Receives Approval for HYCAMTIN(R) (topotecan) Capsules for the Treatment of Relapsed Small Cell Lung Cancer
4. Mayo Clinic Finds Capsule Endoscopy Can Detect Intestinal Damage Caused by Celiac Disease
5. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
6. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
7. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
8. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
9. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
10. American Oriental Bioengineering to Initiate a Phase One Clinical Trial in the United States of AOBO-001 Oral Capsule
11. Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... 18, 2017  Adaptive Sound Technologies, Inc. (ASTI), the leading ... with Hyatt Place Nashville/Downtown to deliver the best sleep ... therapy machines in over two hundred of its guest ... parts of having a great stay is sleeping well," ... Place Nashville/Downtown. "We,re pleased to be able to offer ...
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, ... products to treat a variety of dermatological diseases, ... compound DMT210, in a Phase 2 acne rosacea ... to downregulate the proinflammatory cytokines in the skin ... acne rosacea. This clinical trial, ...
(Date:1/18/2017)... The report " Automated Breast Ultrasound System (ABUS) Market ... End User (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, Regional Outlook (U.S., ... , Germany , UK, France , ... , China , Japan , ... Saudi Arabia , UAE, South Africa ), ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... 19, 2017 , ... Fillers are known for building youthful ... that popular cosmetic fillers can enhance earlobes and rejuvenate an aging ... the MilfordMD Cosmetic Dermatology Surgery & Laser Center, in Milford, Penn. “People often ...
(Date:1/18/2017)... Baltimore, MD (PRWEB) , ... January 18, 2017 ... ... University of Maryland Fischell Department of Bioengineering are collaborating on a research project ... professor in bioengineering, the project seeks to use nanotechnology to control the disease ...
(Date:1/18/2017)... ... January 18, 2017 , ... PrideStaff, a national, ... Franchise Development, Paula Turner Pizarro, was recently featured on Fox Business Network's Worldwide ... of top business leaders from across the globe, provides viewers an opportunity to ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... be presenting at the upcoming WCBP Conference, to be held at the Mayflower ...
(Date:1/18/2017)... , ... January 18, 2017 , ... Floundering on New ... Month and the perfect time for a reset. The U.S. Apple Association agrees and ... combat many of the factors that contribute to heart disease. , The U.S. Apple ...
Breaking Medicine News(10 mins):